Source: BBC News
Follow this link to view the full text
Date of publication: January 2013
Publication type: News story
In a nutshell: NICE have now recommended ranibizumab as a potential eye saving treatment option for some people with visual impairment caused by diabetic macular oedema in new draft guidance. This reverses a decision in 2011 which found that the drug was too expensive.
Length of publication: 1 web page
Source: Health Management Bulletin, Lancashire Teaching Hospitals
Some important notes: Follow this link to read the rapid review of TA237 recommendations on the NICE web site